BURLINGAME, Ca. – The California stem
cell agency and a Stanford-Salk consortium have yet to come to terms
on a final agreement on a $40 million stem cell genomics award.
The governing board of the agency
approved the proposal in late January during a process that was
marked by controversy, including complaints about irregularities,unfairness, score manipulation and the role of its president, AlanTrounson.
All awards are subject to review by the
agency's staff, which works out final details and assures that all terms
are met.
Asked about the status of the award,
Kevin McCormack, senior director of public communications for CIRM,
said this morning that the agency was still talking with the
consortium. He did not go into details about what issues are
involved.
No comments:
Post a Comment